Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
183,558,579
-
Total 13F shares
-
24,229,222
-
Share change
-
-417,685
-
Total reported value
-
$201,828,829
-
Price per share
-
$8.33
-
Number of holders
-
56
-
Value change
-
-$7,802,513
-
Number of buys
-
31
-
Number of sells
-
24
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q3 2014
As of 30 Sep 2014,
HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,229,222 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, VHCP Management, LLC, PERCEPTIVE ADVISORS LLC, Tekla Capital Management LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Cormorant Asset Management, LLC, and KINGDON CAPITAL MANAGEMENT, L.L.C..
This page lists
56
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.